[Other] A randomized phase 2 study combining midostaurin, low-dose cytarabine and venetoclax in newly diagnosed AML ≡60 years

LC1996 Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-10-30 21:14
Reward20points

journalㄩBlood Journal

AuthorsㄩChong Chyn Chua; Wei-Hsun Hsun Hsu; Anoop K. Enjeti; Ashish Bajel; Paula Marlton; Shaun A Fleming; Devendra K. Hiwase; Chun-kei-kris Kris Ma; Peter J. Browett; Carolyn S. Grove; ShuhYing Tan; Travis Perera; Jad Othman; Hannah Rose; Julian P Cooney; Edward S Morris; Derek McCulloch; Kate Mason; Rachel M Koldej; Amanda Johnston; Stephen B Ting; David Ritchie; Natasha S Anstee; John Reynolds; Andrew H Wei

Published dateㄩ--

DOIㄩ10.1182/blood.2026035389

PDF linkㄩhttps://ashpublications.org/bloo ... lood.2026035389.pdf

Article linkㄩhttps://doi.org/10.1182/blood.2026035389

Article SourceㄩAmerican Society of Hematology﹝


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Junior Member
  • post

  • reply

  • points

    130


Daily Top Contributors

Return to the list